We are live on ! Find out more
EWTX icon

Edgewise Therapeutics
EWTX

58 hedge funds and large institutions have $769M invested in Edgewise Therapeutics in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

525% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 4

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

21% more funds holding

Funds holding: 48 → 58 (+10)

4.58% more ownership

Funds ownership: 97.52% → 102.09% (+4.6%)

3% less capital invested

Capital invested by funds: $796M → $769M (-$26.4M)

Holders
58
Holders Change
+10
Holders Change %
+20.83%
% of All Funds
0.89%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
17
Increased
25
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$26.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$11M
3
State Street
State Street
Massachusetts
+$5.93M
4
CAM
Cormorant Asset Management
Massachusetts
+$3.51M
5
Northern Trust
Northern Trust
Illinois
+$3.36M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.8M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$9.95M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$3.7M
4
CS
Credit Suisse
Switzerland
-$1.63M
5
OCA
Octagon Capital Advisors
New York
-$830K
Name Holding Trade Value Shares
Change 		Change in
Stake
VEA
51
Virtus ETF Advisers
New York
$131K +$155K +8,604 New
Legal & General Group
52
Legal & General Group
United Kingdom
$71K +$50.1K +2,786 +149%
AIP
53
Ameritas Investment Partners
Nebraska
$46K +$36.4K +2,023 +209%
SO
54
STRS Ohio
Ohio
$44K – – –
TRCT
55
Tower Research Capital (TRC)
New York
$20K +$14.6K +810 +172%
Daiwa Securities Group
56
Daiwa Securities Group
Japan
$2K +$2.59K +144 New
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$289 +$341K +18,934 New
CS
58
Credit Suisse
Switzerland
– -$1.63M -98,395 Closed
OCA
59
Octagon Capital Advisors
New York
– -$830K -50,000 Closed
HS
60
HighVista Strategies
Massachusetts
– -$650K -39,133 Closed
SCM
61
Soleus Capital Management
Connecticut
– -$520K -31,300 Closed
D.E. Shaw & Co
62
D.E. Shaw & Co
New York
– -$227K -13,695 Closed
PPA
63
Parametric Portfolio Associates
Washington
– -$176K -10,629 Closed
Nisa Investment Advisors
64
Nisa Investment Advisors
Missouri
– -$170 -10,257 Closed
SOW
65
State of Wyoming
Wyoming
– -$36 -2 -7%
1 2
3

EWTX Hedge Fund Activity: Q4 2021 in Review

58 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Edgewise Therapeutics (EWTX) for Q4 2021, worth a combined $769M — down 3.3% from $796M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new EWTX positions and 7 closed out — a net gain of 10 holders — while 25 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $26.4M. The largest seller was Fidelity Investments, cutting an estimated $11.8M.

  • 58 institutional investors held Edgewise Therapeutics (EWTX) as of Q4 2021, up from 48 in Q3 2021.
  • Funds reported $769M of Edgewise Therapeutics stock for Q4 2021, down 3.3% quarter-over-quarter.
  • 17 funds opened new Edgewise Therapeutics positions in Q4 2021 and 7 closed out, a net change of +10 holders.
  • The largest Edgewise Therapeutics buyer in Q4 2021 was BlackRock, an estimated $26.4M added.
  • The largest Edgewise Therapeutics seller in Q4 2021 was Fidelity Investments, an estimated $11.8M sold.

Based on aggregated 13F filings for Q4 2021.